These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3037416)

  • 21. Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors.
    Zukin SR; Brady KT; Slifer BL; Balster RL
    Brain Res; 1984 Feb; 294(1):174-7. PubMed ID: 6199090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between regulation of morphine-induced EEG effects and changes in naloxone sensitivity.
    Paquette NC; Young GA
    Eur J Pharmacol; 1991 Apr; 196(1):61-7. PubMed ID: 1678713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tripelennamine interactions with the psychotomimetic sigma agonist N-allylnormetazocine.
    Vaupel DB
    Pharmacol Biochem Behav; 1989 Jul; 33(3):717-20. PubMed ID: 2555824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.
    Halberstadt AL; Hyun J; Ruderman MA; Powell SB
    Pharmacol Biochem Behav; 2016 Sep; 148():69-75. PubMed ID: 27236030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of acute and chronic administration of (+)SKF 10,047 on body temperature in the rat.
    Bejanian M; Pechnick RN; George R
    NIDA Res Monogr; 1989; 95():492-3. PubMed ID: 2561840
    [No Abstract]   [Full Text] [Related]  

  • 26. N-allylnormetazocine (SKF-10,047): the induction of feeding by a putative sigma agonist.
    Gosnell BA; Levine AS; Morley JE
    Pharmacol Biochem Behav; 1983 Nov; 19(5):737-42. PubMed ID: 6316372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antinociceptive studies of the optical isomers of N-allylnormetazocine (SKF 10,047).
    Aceto MD; May EL
    Eur J Pharmacol; 1983 Jul; 91(2-3):267-72. PubMed ID: 6311580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential stereospecific effects of mu, kappa, and sigma opioid agonists on cortical EEG power spectra in the rat.
    Young GA; Khazan N
    NIDA Res Monogr; 1983 Apr; 43():190-5. PubMed ID: 6308453
    [No Abstract]   [Full Text] [Related]  

  • 29. Reinforcing properties of stereoisomers of the putative sigma agonists N-allylnormetazocine and cyclazocine in rhesus monkeys.
    Slifer BL; Balster RL
    J Pharmacol Exp Ther; 1983 Jun; 225(3):522-8. PubMed ID: 6306209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of phencyclidine, SKF 10,047 and related psychotomimetic agents on N-methyl-D-aspartate receptor mediated synaptic responses in rat hippocampal slices.
    Coan EJ; Collingridge GL
    Br J Pharmacol; 1987 Jul; 91(3):547-56. PubMed ID: 3038243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity.
    Freeman AS; Bunney BS
    Eur J Pharmacol; 1984 Sep; 104(3-4):287-93. PubMed ID: 6094217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential protracted effects of morphine and ethylketocyclazocine challenges on EEG and behavior in the rat.
    Young GA; Khazan N
    Eur J Pharmacol; 1986 Jun; 125(2):265-71. PubMed ID: 3527723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of acute delta 9-THC administration on EEG and EEG power spectra in the rat.
    Buonamici M; Young GA; Khazan N
    Neuropharmacology; 1982 Aug; 21(8):825-9. PubMed ID: 6289162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioural and electoencephalographic interactions between haloperidol and PCP/sigma ligands in the rat.
    Sagratella S; Scotti de Carolis A; Pèzzola A; Popoli P
    Psychopharmacology (Berl); 1991; 105(4):485-91. PubMed ID: 1685250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aging and day-night rhythms in feeding in mice: effects of the putative sigma opiate agonist, N-allylnormetazocine (SKF-10,047).
    Kavaliers M; Hirst M
    Neurobiol Aging; 1986; 7(3):179-83. PubMed ID: 3014359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiating opioids by their pupillary effects in the rat.
    Robin M; Kirby A; Messner S; Geller EB; Adler MW
    Life Sci; 1985 Apr; 36(17):1669-77. PubMed ID: 2985902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic effects of N-allylnormetazocine (SKF-10047).
    Iwamoto ET
    NIDA Res Monogr; 1981 Feb; 34():82-8. PubMed ID: 6783955
    [No Abstract]   [Full Text] [Related]  

  • 39. Dynorphin A-(1-13)-morphine interactions: quantitative and qualitative EEG properties differ in morphine-naive vs. morphine-tolerant rats.
    Meng Y; Young GA
    Brain Res Bull; 1994; 33(3):255-65. PubMed ID: 7904888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat.
    Mattia A; Marquis KL; Leccese AP; el-Fakahany EE; Moreton JE
    J Pharmacol Exp Ther; 1988 Aug; 246(2):797-802. PubMed ID: 2841454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.